Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses

Detalles Bibliográficos
Autores principales: Schmiedeberg, Kristin, Vuilleumier, Nicolas, Pagano, Sabrina, Albrich, Werner C, Ludewig, Burkhard, Kempis, Johannes von, Rubbert-Roth, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547803/
https://www.ncbi.nlm.nih.gov/pubmed/34723209
http://dx.doi.org/10.1016/S2665-9913(21)00328-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547803/
https://www.ncbi.nlm.nih.gov/pubmed/34723209
http://dx.doi.org/10.1016/S2665-9913(21)00328-3

Ejemplares similares